Immunovant
IMVT
#3168
Rank
โ‚ฌ3.63 B
Marketcap
24,76 โ‚ฌ
Share price
0.78%
Change (1 day)
-34.18%
Change (1 year)

Revenue for Immunovant (IMVT)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immunovant from 2019 to 2024

2020202120222023โ‚ฌ0M0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA